909 related articles for article (PubMed ID: 14750252)
1. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
5. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
6. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
10. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
14. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
15. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
16. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
18. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G
J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
[TBL] [Abstract][Full Text] [Related]
20. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]